Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jennifer Wren
OpenAlex ID:
A5041283231
Evaluating a Value-Based, Measurable Residual Disease (MRD) - Focused Clinical Pathway in Patients with Newly Diagnosed Multiple Myeloma
2025
·
Kati O’Brien
, Carl Anthony Blau
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Study Assessing the All4Cure Health Technology Intervention on Patient Activation in Multiple Myeloma
2024
·
Leena Chhun
, Dmytro Assonov
, et al.
·
Blood
Study Assessing the All4Cure Health Technology Intervention on Patient Activation in Multiple Myeloma
2023
·
Mehdi M. Moezi
, Mohamad Kanaan
, et al.
·
Blood
Characteristics of a Comprehensive, Continuously Updated Longitudinal Database for Multiple Myeloma
2021
·
C. Anthony Blau
, Grace Nam
, et al.
·
Blood
Variation in the Treatment of Multiple Myeloma in the Real World
2020
·
Joshua Richter
, Leena Chhun
, et al.
·
Blood
Show more works
View as search
Works count:
5
Citation count:
H-index:
I10-index:
Year
Topic
Type
